Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs.

Francesca AlgieriJosé Garrido-MesaTeresa VezzaMaría Jesús Rodríguez-SojoMaría Elena Rodríguez-CabezasMónica OlivaresFederico GarcíaJulio GálvezRocío MorónAlba Rodríguez-Nogales

Published in: European journal of nutrition (2020)

Among the probiotics assayed, Lactobacillus fermentum CECT5716 and Escherichia coli Nissle 1917 appear to present the best intestinal anti-inflammatory effects, being the latter one of the few probiotics with reputed efficacy in human IBD. Therefore, Lactobacillus fermentum CECT5716 could be considered as a complementary nutritional strategy for IBD treatment.

Keyphrases

escherichia coli
ulcerative colitis
endothelial cells
induced pluripotent stem cells
lactic acid
staphylococcus aureus
combination therapy
multidrug resistant
replacement therapy
candida albicans